Literature DB >> 18938225

Mu opioid receptor knockdown in the substantia nigra/ventral tegmental area by synthetic small interfering RNA blocks the rewarding and locomotor effects of heroin.

Y Zhang1, M Landthaler, S D Schlussman, V Yuferov, A Ho, T Tuschl, M J Kreek.   

Abstract

Mu opioid receptors (MOP-r) play an important role in the rewarding and locomotor stimulatory effects of heroin. The aim of the current study was to determine whether infusion of small interfering RNAs (siRNA) targeting MOP-r into the midbrain could knock down MOP-r mRNA and affect heroin-induced locomotor activity or heroin-induced conditioned place preference. Ten-week-old male C57BL/6J mice were surgically implanted bilaterally with guide cannulae directed between the substantia nigra and ventral tegmental area. After 4 days' recovery, mice were infused bilaterally with siRNAs that target the MOP-r (2 mMx0.75 microl/side/day for 3 days) or control siRNA. Seven days after the last infusion, a procedure for conditioned place preference was begun with four heroin (3 mg/kg i.p.) administration sessions alternating with four saline sessions. While heroin induced an increase in locomotor activity in all groups, siRNAs targeting specific regions of MOP-r significantly attenuated this effect. Of particular interest, mice infused with specific siRNAs targeting the MOP-r failed to develop and express conditioned place preference to heroin, or showed a significantly attenuated preference. These alterations in reward-related behaviors are likely due to the reduction in MOP-r mRNA and protein, shown in separate studies by in situ hybridization and autoradiography using the same MOP-r- siRNA infusions. Taken together, these studies demonstrate the utility of siRNA in the neurobiological study of specific components of the reward system and should contribute to the study of other complex behaviors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18938225      PMCID: PMC3977655          DOI: 10.1016/j.neuroscience.2008.09.039

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  38 in total

1.  mu-Opioid receptor knockout mice do not self-administer alcohol.

Authors:  A J Roberts; J S McDonald; C J Heyser; B L Kieffer; H W Matthes; G F Koob; L H Gold
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

2.  Time course and effective spread of lidocaine and tetrodotoxin delivered via microdialysis: an electrophysiological study in cerebral cortex.

Authors:  S E Boehnke; D D Rasmusson
Journal:  J Neurosci Methods       Date:  2001-02-15       Impact factor: 2.390

3.  Designing effective siRNAs with off-target control.

Authors:  Ola Snøve; Magnar Nedland; Ståle H Fjeldstad; Håkon Humberset; Olaf R Birkeland; Thomas Grünfeld; Pål Saetrom
Journal:  Biochem Biophys Res Commun       Date:  2004-12-17       Impact factor: 3.575

4.  Global down-regulation of gene expression in the brain using RNA interference, with emphasis on monoamine transporters and GPCRs: implications for target characterization in psychiatric and neurological disorders.

Authors:  Daniel Hoyer; Deepak R Thakker; François Natt; Rainer Maier; Dieter Huesken; Matthias Müller; Peter Flor; Herman VAN DER Putten; Markus Schmutz; Graeme Bilbe; John F Cryan
Journal:  J Recept Signal Transduct Res       Date:  2006       Impact factor: 2.092

Review 5.  The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?

Authors:  R Christopher Pierce; Vidhya Kumaresan
Journal:  Neurosci Biobehav Rev       Date:  2005-08-11       Impact factor: 8.989

Review 6.  Therapeutic short hairpin RNA expression in the liver: viral targets and vectors.

Authors:  D Grimm; M A Kay
Journal:  Gene Ther       Date:  2006-03       Impact factor: 5.250

7.  Morphine self-administration in mu-opioid receptor-deficient mice.

Authors:  A Becker; G Grecksch; R Brödemann; J Kraus; B Peters; H Schroeder; W Thiemann; H H Loh; V Höllt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-06       Impact factor: 3.000

8.  Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference.

Authors:  Deepak R Thakker; Francois Natt; Dieter Hüsken; Rainer Maier; Matthias Müller; Herman van der Putten; Daniel Hoyer; John F Cryan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

Review 9.  Buprenorphine and naloxone for heroin dependence.

Authors:  R E Johnson; J C McCagh
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

Review 10.  RNAi silencing in mouse models of neurodegenerative diseases.

Authors:  Mohamed H Farah
Journal:  Curr Drug Deliv       Date:  2007-04       Impact factor: 2.565

View more
  16 in total

Review 1.  New insights into the specificity and plasticity of reward and aversion encoding in the mesolimbic system.

Authors:  Susan F Volman; Stephan Lammel; Elyssa B Margolis; Yunbok Kim; Jocelyn M Richard; Mitchell F Roitman; Mary Kay Lobo
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

2.  Direct bidirectional μ-opioid control of midbrain dopamine neurons.

Authors:  Elyssa B Margolis; Gregory O Hjelmstad; Wakako Fujita; Howard L Fields
Journal:  J Neurosci       Date:  2014-10-29       Impact factor: 6.167

Review 3.  Understanding opioid reward.

Authors:  Howard L Fields; Elyssa B Margolis
Journal:  Trends Neurosci       Date:  2015-01-29       Impact factor: 13.837

4.  Tolerance and sensitization to chronic escalating dose heroin following extended withdrawal in Fischer rats: possible role of mu-opioid receptors.

Authors:  Katharine M Seip-Cammack; Brian Reed; Yong Zhang; Ann Ho; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2012-07-25       Impact factor: 4.530

Review 5.  Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.

Authors:  Mary Jeanne Kreek; Orna Levran; Brian Reed; Stefan D Schlussman; Yan Zhou; Eduardo R Butelman
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

6.  Overview and historical perspective of four papers presented on research related to the endogenous opioid system.

Authors:  Mary Jeanne Kreek
Journal:  Drug Alcohol Depend       Date:  2010-04-18       Impact factor: 4.492

7.  Fos activation of selective afferents to ventral tegmental area during cue-induced reinstatement of cocaine seeking in rats.

Authors:  Stephen V Mahler; Gary S Aston-Jones
Journal:  J Neurosci       Date:  2012-09-19       Impact factor: 6.167

8.  Oxycodone-induced conditioned place preference and sensitization of locomotor activity in adolescent and adult mice.

Authors:  Keiichi Niikura; Ann Ho; Mary Jeanne Kreek; Yong Zhang
Journal:  Pharmacol Biochem Behav       Date:  2013-07-01       Impact factor: 3.533

Review 9.  Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.

Authors:  Yan Zhou; Dmitri Proudnikov; Vadim Yuferov; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2009-11-12       Impact factor: 3.252

Review 10.  Opiate and cocaine addiction: from bench to clinic and back to the bench.

Authors:  Mary Jeanne Kreek; Yan Zhou; Eduardo R Butelman; Orna Levran
Journal:  Curr Opin Pharmacol       Date:  2009-01-18       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.